ANTARES PHARMA, INC.
DelistedCIK 1016169fmd_198E9QV8ZP4F563DMCD7MRCRKYManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2009 to Mar 31, 2022, 49 periods
Latest annual · FY2021
Millions- Total revenues
- 184
- Gross profit
- 73
- Operating income
- 66
- Net income
- 46
- Free cash flow
- 30
Latest quarter · Q1 FY2022
Millions- Total revenues
- 42
- Operating income
- (3)
- Net income
- (2)
- Free cash flow
- (5)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2018 to FY2021
- +42.5%
- Revenue, 5 yearsFY2016 to FY2021
- +28.6%
- Net income, 5 yearsFY2016 to FY2021
- n/m
ANTARES PHARMA, INC. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2021 | FY2020 | Change | Source |
|---|---|---|---|---|
| Revenue | $184 million | $149.6 million | +23% | 10-K 2022-03-03 · proof |
| Operating income | $65.9 million | $13.6 million | +384.1% | 10-K 2022-03-03 · proof |
| Net income | $46.3 million | $56.2 million | -17.6% | 10-K 2022-03-03 · proof |
| Cash from operating activities | $36.6 million | $21.3 million | +71.8% | 10-K 2022-03-03 · proof |
| Free cash flow | $30 million | $11.7 million | +156.3% | 10-K 2022-03-03 · proof |
| Total assets | $257.5 million | $212.5 million | +21.2% | 10-K 2022-03-03 · proof |
| Total liabilities | $81.7 million | $93.4 million | -12.5% | 10-K 2022-03-03 · proof |
| Cash and cash equivalents | $65.9 million | $53.1 million | +24% | 10-K 2022-03-03 · proof |
| Total debt | $19.7 million | $40.9 million | -51.7% | 10-K 2022-03-03 · proof |
- What was ANTARES PHARMA, INC.'s revenue in fiscal 2021?
- ANTARES PHARMA, INC. reported revenue of $184 million for fiscal 2021 (the year ended Dec 31, 2021), against $149.6 million the year before (+23%). Source: the 10-K filed with the SEC on Mar 3, 2022. SEC
- What was ANTARES PHARMA, INC.'s operating income in fiscal 2021?
- ANTARES PHARMA, INC. reported operating income of $65.9 million for fiscal 2021 (the year ended Dec 31, 2021), against $13.6 million the year before (+384.1%). Source: the 10-K filed with the SEC on Mar 3, 2022. SEC
- What was ANTARES PHARMA, INC.'s net income in fiscal 2021?
- ANTARES PHARMA, INC. reported net income of $46.3 million for fiscal 2021 (the year ended Dec 31, 2021), against $56.2 million the year before (-17.6%). Source: the 10-K filed with the SEC on Mar 3, 2022. SEC
- What was ANTARES PHARMA, INC.'s cash from operating activities in fiscal 2021?
- ANTARES PHARMA, INC. reported cash from operating activities of $36.6 million for fiscal 2021 (the year ended Dec 31, 2021), against $21.3 million the year before (+71.8%). Source: the 10-K filed with the SEC on Mar 3, 2022. SEC
- What was ANTARES PHARMA, INC.'s free cash flow in fiscal 2021?
- ANTARES PHARMA, INC. reported free cash flow of $30 million for fiscal 2021 (the year ended Dec 31, 2021), against $11.7 million the year before (+156.3%). Source: the 10-K filed with the SEC on Mar 3, 2022. SEC
- What are ANTARES PHARMA, INC.'s total assets?
- As of Dec 31, 2021, ANTARES PHARMA, INC. reported total assets of $257.5 million, against $212.5 million a year earlier (+21.2%). Source: the 10-K filed with the SEC on Mar 3, 2022. SEC
- What are ANTARES PHARMA, INC.'s total liabilities?
- As of Dec 31, 2021, ANTARES PHARMA, INC. reported total liabilities of $81.7 million, against $93.4 million a year earlier (-12.5%). Source: the 10-K filed with the SEC on Mar 3, 2022. SEC
- What are ANTARES PHARMA, INC.'s cash and cash equivalents?
- As of Dec 31, 2021, ANTARES PHARMA, INC. reported cash and cash equivalents of $65.9 million, against $53.1 million a year earlier (+24%). Source: the 10-K filed with the SEC on Mar 3, 2022. SEC
- What is ANTARES PHARMA, INC.'s total debt?
- As of Dec 31, 2021, ANTARES PHARMA, INC. reported total debt of $19.7 million, against $40.9 million a year earlier (-51.7%). Source: the 10-K filed with the SEC on Mar 3, 2022. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1016169&period_type=annual&limit=5"Information only, not investment advice.